Glipizide Tablet
Product Images NDC 51655-180

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 180 26 Rev A 06 20)

Glipizide is a drug used to treat type 2 diabetes. It is available in the form of tablets containing 5 milligrams of the active ingredient. The medication is sold in a bottle containing 90 tablets and should be stored at room temperature. The drug should be kept in its original container and out of reach of children. The repackaging of this medication has been done by Northwind Pharmaceuticals in Indianapolis, IN. The label contains additional information, including the expiration date and lot number. Please consult the package insert for dosage instructions.*

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.